|
|
|
|
| LEADER |
01641nam a22003375i 4500 |
| 001 |
000278583 |
| 005 |
20210618080401.0 |
| 007 |
cr nn 008mamaa |
| 008 |
170710s2017 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319239101
|
| 024 |
7 |
|
|a 10.1007/978-3-319-23910-1
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Cancer Vaccines /
|c edited by Natalia Savelyeva, Christian Ottensmeier.
|
| 250 |
|
|
|a 1st ed. 2017.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2017.
|
| 300 |
|
|
|a VII, 210 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Current Topics in Microbiology and Immunology,
|v 405
|
| 505 |
0 |
|
|a New Approaches in Immunotherapy for the treatment of Lung Cancer -- Novel approaches for vaccination against HPV-induced cancers -- Tapping the potential of DNA Delivery with Electroporation for Cancer Immunotherapy -- Targeted immunotherapy designed to treat Muc1-expressing solid tumour -- Chimeric DNA vaccines: an effective way to overcome immune tolerance -- Linked CD4 T-cell help: broadening immune attack against cancer by vaccination -- mRNA cancer vaccines – Messages that prevail -- The Use of Anti-CD40 mAb in Cancer.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Vaccines.
|
| 650 |
1 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Vaccine.
|
| 700 |
1 |
|
|a Savelyeva, Natalia.
|e editor.
|
| 700 |
1 |
|
|a Ottensmeier, Christian.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|